Zinc

What Zinc does

Zinc is a London-based venture builder founded in 2017 (legal entity Zinc Ventures Limited; FCA-regulated via Zinc Investment Management LLP) that backs early-stage science-led startups in health and environment. Its core offering is a Venture Building Platform combining four forms of capital — Human Capital (talent networks, co-founders, team building), Intellectual Capital (IP strategy, product and science development), Social Capital (expert, customer and investor networks), and Financial Capital (pre-seed investment up to £250k, plus grant support) — deployed through 9-month mission-led programmes. Zinc's operating model is structured around three pillars: Investment (pre-seed venture backing at inception-to-seed stage), Zinc Innovation Partners (bespoke mission-led programmes delivered with funders such as UKRI, NIHR, Vivensa, and Discovery Spark, plus university partners including LSE, Queen's Belfast and Oxford), and Inflection by Zinc (an AI-native career platform for mid-career professionals targeting 100,000 users, currently paused).

Zinc's revenue mechanics are diversified across three streams. The primary stream is investment returns from a portfolio of 41 Science-for-Impact ventures (therapeutics, engineering biology, clinical services, clean technologies) backed by a $41 million tech-for-good fund raised in May 2022, with carry potential on exits. The second stream is fees from designing and delivering ZIP programmes (e.g., UKRI Food Systems Catalyst, Zinc Innovation Fellowships) — professional services revenue from institutional clients. The third stream, subscription-based revenue from Inflection, is presently paused. The firm holds early backing from LocalGlobe, Atomico and the London School of Economics (£3M, May 2018) and is led by co-founders Paul Kirby and Ella Goldner (Managing Partners), Polly Mackenzie (CEO of Innovation Partners) and Rachel Carey (Chief Scientist), with Saul Klein as Board Member.

Name

Zinc

Legal name

Zinc Ventures Limited

Website

http://www.zinc.vc/

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Zinc is a London-based venture builder founded in 2017 that backs early-stage science-led startups in health and environment through pre-seed investment (£250k), venture building support across four capital forms, and mission-led innovation partnerships with funders and universities.

Ownership category

akta.pro rank

Product category

Venture Capital & Venture Building

NAICS

Miscellaneous Intermediation (52391), Scientific Research and Development Services (5417)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Venture Studios / Company Builders (FSANAAAH)

Keywords

• Venture capital
• Pre-seed investment
• Venture building
• Impact investing
• Innovation partnerships

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Investment Returns: Returns from portfolio company exits through the VC investment model, investing up to £250k initially in Science-for-Impact ventures from start to seed stage
2. Innovation Partnership Programs: Fees from designing and delivering mission-led programmes with leading funders, universities, and institutions (e.g., UKRI Food Systems Catalyst, Zinc Innovation Fellowships)
3. Inflection Platform: Guided programme and peer-to-peer community subscription model for mid-career professionals seeking impact-driven career transitions

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Zinc is a venture capital and venture building platform that backs exceptional entrepreneurs building Science-for-Impact ventures in health and environment from inception through seed stage. It invests up to £250,000 as first investor partner and pairs that capital with hands-on venture building support through Human Capital (talent networks), Intellectual Capital (IP and product development), Social Capital (expert, customer and investor networks) and Financial Capital (grants and follow-on). It also delivers mission-led innovation programmes for funders, universities and institutions, and operates the Inflection career platform for mid-career professionals pursuing impact-driven work.

Product overview

Zinc is a Science-for-Impact venture building and investment platform with three interconnected pillars: Investment (pre-seed funding and venture building for health and environment startups), Zinc Innovation Partners (programmes with universities, funders and institutions to support science commercialization), and Inflection (a platform for mid-career professionals seeking career transitions toward impact-driven work). Zinc provides initial investments of up to £250,000 through its Venture Building Platform built on four forms of capital: Human Capital, Intellectual Capital, Social Capital, and Financial Capital. The platform backs Science-for-Impact ventures at inception stage, spanning therapeutics, engineering biology, clinical services, clean technologies, and beyond.

Differentiator

Problem solved

Functional benefit

Brands

• Inflection by Zinc: A platform designed to help mid-career professionals achieve impact in their careers through science, featuring peer-to-peer pods, coaching, and AI-native platform
• Zinc Innovation Partners

Products and services

• Pre-Seed Investment & Venture Building Zinc's flagship offering for Science-for-Impact founders at the earliest and riskiest stages (Start to Seed) in health and environment. Provides up to £250,000 initial investment as first investor partner, combined with the Zinc Venture Building Platform delivering Human Capital (talent networks, co-founder and team building), Intellectual Capital (IP strategy, product and science development), Social Capital (expert, customer and investor networks), and Financial Capital (grant support and follow-on). Portfolio spans therapeutics, engineering biology, clinical services, clean technologies and beyond.
• Zinc Innovation Partners Programmes Mission-led programmes designed and delivered with leading funders, universities and institutions to reimagine how science achieves impact. Brings together multidisciplinary research, entrepreneurial experience and practical commercialisation support. Notable programmes include the UKRI Food Systems Catalyst and Zinc Innovation Fellowships (with Vivensa Foundation and NIHR), which have supported over 150 research teams.
• Inflection by Zinc AI-native platform designed to help mid-career professionals (10-25 years experience from science, business and public sector) reimagine their careers for impact. Combines peer-to-peer pods, executive coaching and AI-enabled collaboration tools to support bold career shifts toward purpose and impact.

Quantifiable outcome

• 41 Science-for-Impact ventures in portfolio
• +3 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Discovery SparkcoreStrategic or Co-development Partner · 9 March 2026Discovery Spark is a startup growth programme at Discovery Park supporting early-stage cardiovascular health companies. Zinc partnered with Discovery Spark for the Cardiovascular Innovation Programme where SignaCor was selected as winner.
• UKRI (UK Research and Innovation)coreStrategic or Co-development PartnerStrategic partner for multiple programmes including UKRI Food Systems Catalyst bringing together biological and social scientists, and UKRI Healthy Ageing Catalyst Awards. Supported over 150 research teams through these partnerships.
• NIHR (National Institute for Health and Care Research)coreStrategic or Co-development PartnerPartner in Zinc Innovation Fellowships programme alongside Vivensa Foundation, placing exceptional clinical researchers into ventures for mutual knowledge exchange.
• HSBCminorStrategic or Co-development PartnerPartner referenced in relation to Inflection platform development and support for Zinc's Science-for-Impact initiatives.
• Queen's University BelfastminorStrategic or Co-development PartnerUniversity spinout partner for SignaCor, a Queen's University Belfast spinout developing first-in-class therapeutics for hypertrophic cardiomyopathy.
• University of OxfordminorStrategic or Co-development PartnerUniversity spinout partner for IonSight, a University of Oxford spinout developing AI-enabled native mass spectrometry platform for drug discovery.
• Science Entrepreneur Club / BioCapital NetworkminorStrategic or Co-development PartnerPortfolio Lead Matthew McCann co-founded Science Entrepreneur Club, building communities enabling life sciences innovation. BioCapital Network has grown to over 500 life science investors from across the UK.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• SETsquared Partnership: University-led enterprise partnership across five top UK universities (Bath, Bristol, Exeter, Southampton, Surrey) running startup support programmes. Comparable in designing programmes for science commercialization from UK research institutions.
• Octopus Ventures: One of the largest UK VCs with strong early-stage and impact investing presence. Less specialized than Zinc in science-for-impact but overlaps significantly in pre-seed UK venture backing and impact thesis.

Direct peers

• Entrepreneur First: London-based talent-first venture builder that invests in exceptional individuals pre-team, before they have formed companies. Most directly comparable to Zinc in mission, model (cohort programmes, pre-seed investment), and geography.
• Bethnal Green Ventures: Early-stage UK impact VC running accelerator programmes for tech-for-good startups. Highly comparable in mission (tech-for-impact), UK focus, and accelerator-style venture building; Paul Kirby (Zinc co-founder) formerly a Director at BGV.
• Parkwalk Advisors: UK's leading investor in university spinouts, focusing on deep tech and life sciences emerging from UK research institutions. Directly comparable in early-stage science backing; Emilie Syed (Zinc Investment Principal) previously sat on Parkwalk's Investment Committee.
• Cambridge Innovation Capital: UK deep tech and life sciences investor focused on Cambridge ecosystem spinouts. Comparable in deep tech / science tilt, UK university spinout focus, and early-to-growth stage investing across health and environment adjacencies.
• Antler: Global venture builder running cohort-based programmes to identify and back exceptional founders from day zero. Comparable in venture studio model, pre-team talent focus, and programmatic approach, though broader in geography and less focused on science.
• Episode 1 Ventures: UK pre-seed investor backing exceptional founders at the earliest stages. Comparable in stage focus (pre-seed), UK ecosystem, and hands-on venture support model, though broader in sector than Zinc's science-for-impact mandate.
• Ascension Ventures: UK-based early-stage impact VC backing purpose-driven founders. Comparable in mission-led investing focus and UK ecosystem, with strong overlap in backing founders building ventures addressing social and environmental challenges.

Others

• ClearlySo: UK impact investment advisory and intermediary connecting impact ventures with capital. Adjacent rather than direct competitor — operates more as a deal intermediary and advisory in the impact investing ecosystem where Zinc also participates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/zinc-vc
• Xx.com/zincvc

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments31 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zinc